UBE2O and hepatocellular carcinoma: Findings indicate that HCC cells with high levels of UBE2O expression and low levels of IFIT3 expression exhibit strong resistance to interferon α treatment, whereas those with low UBE2O expression and high IFIT3 expression display heightened sensitivity to interferon α (60).